Dr. Reddy’s Q4 and FY16 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.07
May 12, 2016 9:19 AM EDTDr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.07, versus $0.46 reported last year. Revenue for the quarter came in at $567 billion, versus $584 billion reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
... More